- The Philippine Court of Tax Appeals issued a decision on VAT refund rules in CTA Case No. 10725
- A domestic AstraZeneca subsidiary sought a VAT refund for prescription drugs imported in 2020
- The taxpayer paid VAT and filed for exemption based on a drug exemption effective January 1, 2020
- The Commissioner of Internal Revenue did not act on the claim, leading to a court petition
- The Court of Tax Appeals found that most drugs were listed as VAT exempt by the FDA
- All VAT payments were made during the exemption period
- The taxpayer did not report or claim the VAT paid as an input VAT deduction
- The taxpayer was entitled to a partial refund
Source: news.bloombergtax.com
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
Latest Posts in "Philippines"
- The BIR suspends audits of books of accounts until further notice
- Philippine Senate Proposes Abolishing VAT and 3% Tax, Signaling Major Tax Reform
- Philippine Court Clarifies Input VAT Refunds for Zero-Rated Sales in Recent Decision
- Philippine Court Bars VAT Deficiency Collection Due to Expired Three-Year Prescriptive Period
- Philippine Court Clarifies Input VAT Refunds for Zero-Rated Sales in Multinational Branch Case
